MNCs seek restart of refurbished medical device imports

New Delhi, August 19, 2025 — Global med-tech companies have urged the Centre to allow refurbished medical device imports again and include medical devices in India’s repair-services push. The request comes after the drug regulator told customs in January 2025 to stop refurbished device imports because the Medical Devices Rules, 2017 do not provide for such licences. Industry believes a calibrated reopening can lower costs and expand access to imaging and critical-care equipment in tier-2 and tier-3 hospitals. Daijiworld

Background

In January, the Central Drugs Standard Control Organisation (CDSCO) wrote to customs to halt refurbished imports, citing the absence of a licensing pathway under current rules. Domestic manufacturers welcomed the move, arguing it would curb dumping and support Make-in-India capacity. Multinationals, meanwhile, say hospitals lost an affordable route to MRI, CT, cath-lab and anaesthesia systems. Daijiworld

What the industry is asking

According to an ETHealthworld report, multinational members represented by MTaI have asked the government to reinstate refurbished imports with approvals from the Directorate General of Health Services (DGHS) and the Environment Ministry, and to admit medical devices into India’s ERSO (Electronics Repair Services Outsourcing) initiative so India can become a regional repair hub. ETHealthworld.commedgatetoday.com

Why it matters

Refurbished systems typically cost 30–50% less than new units, yet can meet performance norms when OEMs do the refurbishment and the country enforces strong testing and traceability. For district hospitals, that price gap can mean an extra CT scanner on site or faster turnaround for oncology care. However, without strict pre-shipment checks, post-market surveillance and extended service obligations, refurbished inflows can undercut quality and crowd out local manufacturing. A balanced framework is the challenge.

The policy hooks

India has already built a Right to Repair policy architecture and a national portal stewarded by DPIIT. Industry says medical devices should plug into that stack, and ERSO can anchor skilled jobs in repair, calibration and parts management — with clear e-waste rules for end-of-life equipment. Regulators, on the other hand, want an auditable chain: origin, refurbisher credentials, safety tests, radiation checks, warranty, service support and e-waste compliance. MeitYmedgatetoday.com

What a “yes, but” model could look like

  • Allow only OEM-refurbished or OEM-authorised equipment with global UDI traceability and a minimum warranty period.

  • Mandate pre-arrival conformity assessment and radiation safety certification for imaging devices.

  • Tie every import to service-uptime guarantees, spare-parts availability and end-of-life take-back.

  • Ring-fence segments with strong domestic capacity for local-first procurement.

  • Route all transactions through a refurb registry linked to CDSCO’s post-market surveillance.

Expert view

Policy analysts point out that many countries run such hybrid models: refurbished flows are allowed, but only with OEM refurbishment, strict testing and transparent service contracts. That approach preserves patient safety while easing capital costs for public hospitals.

The road ahead

The government will have to weigh access, affordability and Atmanirbhar goals. A pilot with capped volumes, tighter documentation and real-time vigilance may offer evidence without risking the market. Either way, hospitals need clarity soon to plan capex cycles and maintain uptime of critical services.

Related Posts

Jharkhand’s Blood Scandal: Govt Suspends Officials, Launches Probes Amid Calls for NAT Testing Mandate

Ranchi–  In a heartbreaking breach of medical trust, five thalassemia-afflicted children in Jharkhand’s West Singhbhum district have tested HIV-positive after receiving contaminated blood transfusions at Chaibasa Sadar Hospital, exposing glaring…

Shocking Blood Plasma Theft at AIIMS Bhopal: 1,150 Units Stolen and Sold for Rs 11.72 Lakh in Inter-State Racket

Bhopal– A brazen scam at the All India Institute of Medical Sciences (AIIMS) Bhopal has exposed deep rot in India’s premier healthcare institutions, with six individuals—including blood bank staff and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cough Syrup Took Betul Boy’s Voice

Cough Syrup Took Betul Boy’s Voice

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

Seven state-of the-art common infra facilities to come up at Ujjain Medical Devices Park

Seven state-of the-art common infra facilities to come up at Ujjain Medical Devices Park

Kala Amb firm linked to drug racket sealed by NCB

Kala Amb firm linked to drug racket sealed by NCB

Expired medicines: 2 hospitals barred from PM-JAY

Expired medicines: 2 hospitals barred from PM-JAY